Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus ErythematosusKatharina Shaw, Ruth Ann Vleugels, Stephanie Sánchez-Meléndez et al.|JAMA Dermatology|2023Cited by 51
Tocilizumab for refractory morphea in adults: A case seriesSarah Lonowski, Ruth Ann Vleugels, Nathaniel Goldman et al.|JAAD Case Reports|2022Cited by 20
Improvement in dermatomyositis-associated muscle disease with anifrolumabLeila H. Shayegan, Ruth Ann Vleugels, Nnenna Ezeh et al.|British Journal of Dermatology|2025Cited by 12
Intravenous Immunoglobulin and Dermatomyositis-Associated Venous ThromboembolismElizabeth Rotrosen, Ruth Ann Vleugels, Omid Zahedi Niaki et al.|JAMA Dermatology|2023Cited by 11
Improvement in mucosal discoid lupus erythematosus with anifrolumabKatharina S. Shaw, Ruth Ann Vleugels, Dustin Taylor et al.|Clinical and Experimental Dermatology|2023Cited by 10